The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
Identifieur interne : 002948 ( PubMed/Corpus ); précédent : 002947; suivant : 002949The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
Auteurs : William D. Travis ; Elisabeth Brambilla ; Andrew G. Nicholson ; Yasushi Yatabe ; John H M. Austin ; Mary Beth Beasley ; Lucian R. Chirieac ; Sanja Dacic ; Edwina Duhig ; Douglas B. Flieder ; Kim Geisinger ; Fred R. Hirsch ; Yuichi Ishikawa ; Keith M. Kerr ; Masayuki Noguchi ; Giuseppe Pelosi ; Charles A. Powell ; Ming Sound Tsao ; Ignacio WistubaSource :
- Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [ 1556-1380 ] ; 2015.
English descriptors
- KwdEn :
- MESH :
- classification : Lung Neoplasms.
- genetics : Lung Neoplasms.
- organization & administration : World Health Organization.
- pathology : Lung Neoplasms.
- Female, History, 21st Century, Humans, Male.
Abstract
The 2015 World Health Organization (WHO) Classification of Tumors of the Lung, Pleura, Thymus and Heart has just been published with numerous important changes from the 2004 WHO classification. The most significant changes in this edition involve (1) use of immunohistochemistry throughout the classification, (2) a new emphasis on genetic studies, in particular, integration of molecular testing to help personalize treatment strategies for advanced lung cancer patients, (3) a new classification for small biopsies and cytology similar to that proposed in the 2011 Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification, (4) a completely different approach to lung adenocarcinoma as proposed by the 2011 Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification, (5) restricting the diagnosis of large cell carcinoma only to resected tumors that lack any clear morphologic or immunohistochemical differentiation with reclassification of the remaining former large cell carcinoma subtypes into different categories, (6) reclassifying squamous cell carcinomas into keratinizing, nonkeratinizing, and basaloid subtypes with the nonkeratinizing tumors requiring immunohistochemistry proof of squamous differentiation, (7) grouping of neuroendocrine tumors together in one category, (8) adding NUT carcinoma, (9) changing the term sclerosing hemangioma to sclerosing pneumocytoma, (10) changing the name hamartoma to "pulmonary hamartoma," (11) creating a group of PEComatous tumors that include (a) lymphangioleiomyomatosis, (b) PEComa, benign (with clear cell tumor as a variant) and
DOI: 10.1097/JTO.0000000000000630
PubMed: 26291008
Links to Exploration step
pubmed:26291008Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.</title><author><name sortKey="Travis, William D" sort="Travis, William D" uniqKey="Travis W" first="William D" last="Travis">William D. Travis</name><affiliation><nlm:affiliation>Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: travisw@mskcc.org.</nlm:affiliation></affiliation></author><author><name sortKey="Brambilla, Elisabeth" sort="Brambilla, Elisabeth" uniqKey="Brambilla E" first="Elisabeth" last="Brambilla">Elisabeth Brambilla</name><affiliation><nlm:affiliation>Dept d'Anatomie et Cytologie Pathologiques, CHU Albert Michallon, University Joseph Fourier; INSERM U823 Institut Albert Bonniot, Grenoble, France.</nlm:affiliation></affiliation></author><author><name sortKey="Nicholson, Andrew G" sort="Nicholson, Andrew G" uniqKey="Nicholson A" first="Andrew G" last="Nicholson">Andrew G. Nicholson</name><affiliation><nlm:affiliation>Department of Pathology, Royal Brompton Hospital, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Yatabe, Yasushi" sort="Yatabe, Yasushi" uniqKey="Yatabe Y" first="Yasushi" last="Yatabe">Yasushi Yatabe</name><affiliation><nlm:affiliation>Department of Pathology, Aichi Cancer Center, Nagoya, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Austin, John H M" sort="Austin, John H M" uniqKey="Austin J" first="John H M" last="Austin">John H M. Austin</name><affiliation><nlm:affiliation>Department of Radiology, Columbia University Medical Center, New York, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Beasley, Mary Beth" sort="Beasley, Mary Beth" uniqKey="Beasley M" first="Mary Beth" last="Beasley">Mary Beth Beasley</name><affiliation><nlm:affiliation>Department of Pathology, Ichan School of Medicine at Mt Sinai, New York, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Chirieac, Lucian R" sort="Chirieac, Lucian R" uniqKey="Chirieac L" first="Lucian R" last="Chirieac">Lucian R. Chirieac</name><affiliation><nlm:affiliation>Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.</nlm:affiliation></affiliation></author><author><name sortKey="Dacic, Sanja" sort="Dacic, Sanja" uniqKey="Dacic S" first="Sanja" last="Dacic">Sanja Dacic</name><affiliation><nlm:affiliation>Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.</nlm:affiliation></affiliation></author><author><name sortKey="Duhig, Edwina" sort="Duhig, Edwina" uniqKey="Duhig E" first="Edwina" last="Duhig">Edwina Duhig</name><affiliation><nlm:affiliation>Sullivan Nicolaides Pathology, The John Flynn Hospital, Tugun, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Flieder, Douglas B" sort="Flieder, Douglas B" uniqKey="Flieder D" first="Douglas B" last="Flieder">Douglas B. Flieder</name><affiliation><nlm:affiliation>Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.</nlm:affiliation></affiliation></author><author><name sortKey="Geisinger, Kim" sort="Geisinger, Kim" uniqKey="Geisinger K" first="Kim" last="Geisinger">Kim Geisinger</name><affiliation><nlm:affiliation>Department of Pathology, University of Mississippi Medical Center, Jackson, Mississippi.</nlm:affiliation></affiliation></author><author><name sortKey="Hirsch, Fred R" sort="Hirsch, Fred R" uniqKey="Hirsch F" first="Fred R" last="Hirsch">Fred R. Hirsch</name><affiliation><nlm:affiliation>University of Colorado Cancer Center UCHSC, Aurora, Colorado.</nlm:affiliation></affiliation></author><author><name sortKey="Ishikawa, Yuichi" sort="Ishikawa, Yuichi" uniqKey="Ishikawa Y" first="Yuichi" last="Ishikawa">Yuichi Ishikawa</name><affiliation><nlm:affiliation>Department of Pathology, The JFCR Cancer Institute, Tokyo, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Kerr, Keith M" sort="Kerr, Keith M" uniqKey="Kerr K" first="Keith M" last="Kerr">Keith M. Kerr</name><affiliation><nlm:affiliation>Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Noguchi, Masayuki" sort="Noguchi, Masayuki" uniqKey="Noguchi M" first="Masayuki" last="Noguchi">Masayuki Noguchi</name><affiliation><nlm:affiliation>Department of Pathology; Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Pelosi, Giuseppe" sort="Pelosi, Giuseppe" uniqKey="Pelosi G" first="Giuseppe" last="Pelosi">Giuseppe Pelosi</name><affiliation><nlm:affiliation>Department of Pathology and Laboratory Medicine, Istituto Nazionale Tumori, Milan, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Powell, Charles A" sort="Powell, Charles A" uniqKey="Powell C" first="Charles A" last="Powell">Charles A. Powell</name><affiliation><nlm:affiliation>Division of Pulmonary Critical Care and Sleep Medicine, Ichan School of Medicine at Mt Siai, New York, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Tsao, Ming Sound" sort="Tsao, Ming Sound" uniqKey="Tsao M" first="Ming Sound" last="Tsao">Ming Sound Tsao</name><affiliation><nlm:affiliation>Department of Pathology, Princess Margaret Hospital, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Wistuba, Ignacio" sort="Wistuba, Ignacio" uniqKey="Wistuba I" first="Ignacio" last="Wistuba">Ignacio Wistuba</name><affiliation><nlm:affiliation>Department of Pathology, MD Anderson Cancer Center, Houston, Texas.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26291008</idno><idno type="pmid">26291008</idno><idno type="doi">10.1097/JTO.0000000000000630</idno><idno type="wicri:Area/PubMed/Corpus">002948</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002948</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.</title><author><name sortKey="Travis, William D" sort="Travis, William D" uniqKey="Travis W" first="William D" last="Travis">William D. Travis</name><affiliation><nlm:affiliation>Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: travisw@mskcc.org.</nlm:affiliation></affiliation></author><author><name sortKey="Brambilla, Elisabeth" sort="Brambilla, Elisabeth" uniqKey="Brambilla E" first="Elisabeth" last="Brambilla">Elisabeth Brambilla</name><affiliation><nlm:affiliation>Dept d'Anatomie et Cytologie Pathologiques, CHU Albert Michallon, University Joseph Fourier; INSERM U823 Institut Albert Bonniot, Grenoble, France.</nlm:affiliation></affiliation></author><author><name sortKey="Nicholson, Andrew G" sort="Nicholson, Andrew G" uniqKey="Nicholson A" first="Andrew G" last="Nicholson">Andrew G. Nicholson</name><affiliation><nlm:affiliation>Department of Pathology, Royal Brompton Hospital, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Yatabe, Yasushi" sort="Yatabe, Yasushi" uniqKey="Yatabe Y" first="Yasushi" last="Yatabe">Yasushi Yatabe</name><affiliation><nlm:affiliation>Department of Pathology, Aichi Cancer Center, Nagoya, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Austin, John H M" sort="Austin, John H M" uniqKey="Austin J" first="John H M" last="Austin">John H M. Austin</name><affiliation><nlm:affiliation>Department of Radiology, Columbia University Medical Center, New York, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Beasley, Mary Beth" sort="Beasley, Mary Beth" uniqKey="Beasley M" first="Mary Beth" last="Beasley">Mary Beth Beasley</name><affiliation><nlm:affiliation>Department of Pathology, Ichan School of Medicine at Mt Sinai, New York, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Chirieac, Lucian R" sort="Chirieac, Lucian R" uniqKey="Chirieac L" first="Lucian R" last="Chirieac">Lucian R. Chirieac</name><affiliation><nlm:affiliation>Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.</nlm:affiliation></affiliation></author><author><name sortKey="Dacic, Sanja" sort="Dacic, Sanja" uniqKey="Dacic S" first="Sanja" last="Dacic">Sanja Dacic</name><affiliation><nlm:affiliation>Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.</nlm:affiliation></affiliation></author><author><name sortKey="Duhig, Edwina" sort="Duhig, Edwina" uniqKey="Duhig E" first="Edwina" last="Duhig">Edwina Duhig</name><affiliation><nlm:affiliation>Sullivan Nicolaides Pathology, The John Flynn Hospital, Tugun, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Flieder, Douglas B" sort="Flieder, Douglas B" uniqKey="Flieder D" first="Douglas B" last="Flieder">Douglas B. Flieder</name><affiliation><nlm:affiliation>Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.</nlm:affiliation></affiliation></author><author><name sortKey="Geisinger, Kim" sort="Geisinger, Kim" uniqKey="Geisinger K" first="Kim" last="Geisinger">Kim Geisinger</name><affiliation><nlm:affiliation>Department of Pathology, University of Mississippi Medical Center, Jackson, Mississippi.</nlm:affiliation></affiliation></author><author><name sortKey="Hirsch, Fred R" sort="Hirsch, Fred R" uniqKey="Hirsch F" first="Fred R" last="Hirsch">Fred R. Hirsch</name><affiliation><nlm:affiliation>University of Colorado Cancer Center UCHSC, Aurora, Colorado.</nlm:affiliation></affiliation></author><author><name sortKey="Ishikawa, Yuichi" sort="Ishikawa, Yuichi" uniqKey="Ishikawa Y" first="Yuichi" last="Ishikawa">Yuichi Ishikawa</name><affiliation><nlm:affiliation>Department of Pathology, The JFCR Cancer Institute, Tokyo, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Kerr, Keith M" sort="Kerr, Keith M" uniqKey="Kerr K" first="Keith M" last="Kerr">Keith M. Kerr</name><affiliation><nlm:affiliation>Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Noguchi, Masayuki" sort="Noguchi, Masayuki" uniqKey="Noguchi M" first="Masayuki" last="Noguchi">Masayuki Noguchi</name><affiliation><nlm:affiliation>Department of Pathology; Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Pelosi, Giuseppe" sort="Pelosi, Giuseppe" uniqKey="Pelosi G" first="Giuseppe" last="Pelosi">Giuseppe Pelosi</name><affiliation><nlm:affiliation>Department of Pathology and Laboratory Medicine, Istituto Nazionale Tumori, Milan, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Powell, Charles A" sort="Powell, Charles A" uniqKey="Powell C" first="Charles A" last="Powell">Charles A. Powell</name><affiliation><nlm:affiliation>Division of Pulmonary Critical Care and Sleep Medicine, Ichan School of Medicine at Mt Siai, New York, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Tsao, Ming Sound" sort="Tsao, Ming Sound" uniqKey="Tsao M" first="Ming Sound" last="Tsao">Ming Sound Tsao</name><affiliation><nlm:affiliation>Department of Pathology, Princess Margaret Hospital, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Wistuba, Ignacio" sort="Wistuba, Ignacio" uniqKey="Wistuba I" first="Ignacio" last="Wistuba">Ignacio Wistuba</name><affiliation><nlm:affiliation>Department of Pathology, MD Anderson Cancer Center, Houston, Texas.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer</title><idno type="eISSN">1556-1380</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Female</term><term>History, 21st Century</term><term>Humans</term><term>Lung Neoplasms (classification)</term><term>Lung Neoplasms (genetics)</term><term>Lung Neoplasms (pathology)</term><term>Male</term><term>World Health Organization (organization & administration)</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Lung Neoplasms</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Lung Neoplasms</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>World Health Organization</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lung Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>History, 21st Century</term><term>Humans</term><term>Male</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The 2015 World Health Organization (WHO) Classification of Tumors of the Lung, Pleura, Thymus and Heart has just been published with numerous important changes from the 2004 WHO classification. The most significant changes in this edition involve (1) use of immunohistochemistry throughout the classification, (2) a new emphasis on genetic studies, in particular, integration of molecular testing to help personalize treatment strategies for advanced lung cancer patients, (3) a new classification for small biopsies and cytology similar to that proposed in the 2011 Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification, (4) a completely different approach to lung adenocarcinoma as proposed by the 2011 Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification, (5) restricting the diagnosis of large cell carcinoma only to resected tumors that lack any clear morphologic or immunohistochemical differentiation with reclassification of the remaining former large cell carcinoma subtypes into different categories, (6) reclassifying squamous cell carcinomas into keratinizing, nonkeratinizing, and basaloid subtypes with the nonkeratinizing tumors requiring immunohistochemistry proof of squamous differentiation, (7) grouping of neuroendocrine tumors together in one category, (8) adding NUT carcinoma, (9) changing the term sclerosing hemangioma to sclerosing pneumocytoma, (10) changing the name hamartoma to "pulmonary hamartoma," (11) creating a group of PEComatous tumors that include (a) lymphangioleiomyomatosis, (b) PEComa, benign (with clear cell tumor as a variant) and</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26291008</PMID><DateCreated><Year>2015</Year><Month>08</Month><Day>21</Day></DateCreated><DateCompleted><Year>2016</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1556-1380</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>9</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer</Title><ISOAbbreviation>J Thorac Oncol</ISOAbbreviation></Journal><ArticleTitle>The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.</ArticleTitle><Pagination><MedlinePgn>1243-1260</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1556-0864(15)33571-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/JTO.0000000000000630</ELocationID><Abstract><AbstractText>The 2015 World Health Organization (WHO) Classification of Tumors of the Lung, Pleura, Thymus and Heart has just been published with numerous important changes from the 2004 WHO classification. The most significant changes in this edition involve (1) use of immunohistochemistry throughout the classification, (2) a new emphasis on genetic studies, in particular, integration of molecular testing to help personalize treatment strategies for advanced lung cancer patients, (3) a new classification for small biopsies and cytology similar to that proposed in the 2011 Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification, (4) a completely different approach to lung adenocarcinoma as proposed by the 2011 Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification, (5) restricting the diagnosis of large cell carcinoma only to resected tumors that lack any clear morphologic or immunohistochemical differentiation with reclassification of the remaining former large cell carcinoma subtypes into different categories, (6) reclassifying squamous cell carcinomas into keratinizing, nonkeratinizing, and basaloid subtypes with the nonkeratinizing tumors requiring immunohistochemistry proof of squamous differentiation, (7) grouping of neuroendocrine tumors together in one category, (8) adding NUT carcinoma, (9) changing the term sclerosing hemangioma to sclerosing pneumocytoma, (10) changing the name hamartoma to "pulmonary hamartoma," (11) creating a group of PEComatous tumors that include (a) lymphangioleiomyomatosis, (b) PEComa, benign (with clear cell tumor as a variant) and</AbstractText><CopyrightInformation>(c) PEComa, malignant, (12) introducing the entity pulmonary myxoid sarcoma with an EWSR1-CREB1 translocation, (13) adding the entities myoepithelioma and myoepithelial carcinomas, which can show EWSR1 gene rearrangements, (14) recognition of usefulness of WWTR1-CAMTA1 fusions in diagnosis of epithelioid hemangioendotheliomas, (15) adding Erdheim-Chester disease to the lymphoproliferative tumor, and (16) a group of tumors of ectopic origin to include germ cell tumors, intrapulmonary thymoma, melanoma and meningioma.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Travis</LastName><ForeName>William D</ForeName><Initials>WD</Initials><AffiliationInfo><Affiliation>Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: travisw@mskcc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brambilla</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dept d'Anatomie et Cytologie Pathologiques, CHU Albert Michallon, University Joseph Fourier; INSERM U823 Institut Albert Bonniot, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Andrew G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Pathology, Royal Brompton Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yatabe</LastName><ForeName>Yasushi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pathology, Aichi Cancer Center, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Austin</LastName><ForeName>John H M</ForeName><Initials>JHM</Initials><AffiliationInfo><Affiliation>Department of Radiology, Columbia University Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beasley</LastName><ForeName>Mary Beth</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Pathology, Ichan School of Medicine at Mt Sinai, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chirieac</LastName><ForeName>Lucian R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dacic</LastName><ForeName>Sanja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duhig</LastName><ForeName>Edwina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Sullivan Nicolaides Pathology, The John Flynn Hospital, Tugun, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flieder</LastName><ForeName>Douglas B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geisinger</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Mississippi Medical Center, Jackson, Mississippi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirsch</LastName><ForeName>Fred R</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>University of Colorado Cancer Center UCHSC, Aurora, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishikawa</LastName><ForeName>Yuichi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pathology, The JFCR Cancer Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerr</LastName><ForeName>Keith M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noguchi</LastName><ForeName>Masayuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology; Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Istituto Nazionale Tumori, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>Charles A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Critical Care and Sleep Medicine, Ichan School of Medicine at Mt Siai, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsao</LastName><ForeName>Ming Sound</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Pathology, Princess Margaret Hospital, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wistuba</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pathology, MD Anderson Cancer Center, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>WHO Panel</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016456">Historical Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Thorac Oncol</MedlineTA><NlmUniqueID>101274235</NlmUniqueID><ISSNLinking>1556-0864</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Oncol. 2016 Feb;11(2):e25-6</RefSource><PMID Version="1">26811227</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Oncol. 2016 Feb;11(2):e26-7</RefSource><PMID Version="1">26811228</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Oncol. 2015 Sep;10(9):1240-2</RefSource><PMID Version="1">26291007</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049674" MajorTopicYN="N">History, 21st Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26291008</ArticleId><ArticleId IdType="doi">10.1097/JTO.0000000000000630</ArticleId><ArticleId IdType="pii">S1556-0864(15)33571-1</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002948 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002948 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:26291008
|texte= The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26291008" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |